CN1097622A - Styptic powder - Google Patents

Styptic powder Download PDF

Info

Publication number
CN1097622A
CN1097622A CN94107005A CN94107005A CN1097622A CN 1097622 A CN1097622 A CN 1097622A CN 94107005 A CN94107005 A CN 94107005A CN 94107005 A CN94107005 A CN 94107005A CN 1097622 A CN1097622 A CN 1097622A
Authority
CN
China
Prior art keywords
ophicalcitum
bletillae
radix notoginseng
notoginseng powder
rhizoma bletillae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN94107005A
Other languages
Chinese (zh)
Other versions
CN1051236C (en
Inventor
郭文峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94107005A priority Critical patent/CN1051236C/en
Publication of CN1097622A publication Critical patent/CN1097622A/en
Application granted granted Critical
Publication of CN1051236C publication Critical patent/CN1051236C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention has provided a kind of hemostatic Chinese medicine drug hemostasis that is used for and has loose.It is that to select Chinese medicine medicine Ophicalcitum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Notoginseng powder and Calamina for use be raw material, earlier Ophicalcitum, Calamina are forged, quench in vinegar, ground into powder with water and fly through fire respectively, again with the Pseudobulbus Bletillae (Rhizoma Bletillae) through drying, grind into powder and sieve, and then select materials and the Radix Notoginseng powder mix homogeneously above-mentioned, after sterilization, form again.Its part by weight of respectively selecting materials is an Ophicalcitum: the Pseudobulbus Bletillae (Rhizoma Bletillae): Radix Notoginseng powder: Calamina=40: 30: 20: 10.Its internal outer pain of injury has significant hemostasis and analgesic effect.

Description

Styptic powder
The present invention relates to a kind of hemostatic Chinese medicine drug hemostasis that is used for looses.
Being used for hemostatic Chinese medicine medicine at present on the market is representative with " YUNNAN BAIYAO ", this medicine Chang Sheng since throwing in market does not wane, and its reason is that curative effect is better, portably uses conveniently, be applicable to general wound and a small amount of internal hemorrhage, and not good for the big interior wound result of use of amount of bleeding.
The object of the present invention is to provide a kind of curative effect rapid, the Hemostatic of traditional herb medicine drug hemostasis that is used for large-scale interior wound is loose.
The present invention has selected hemostasis and pain-relieving for use, detumescence and promoting granulation, dissolving blood stasis and detoxication, removing dampness is held back the Chinese medicine medicine of skin ulcer, with the Ophicalcitum is principal agent, with the Pseudobulbus Bletillae (Rhizoma Bletillae) is auxiliary medicine, with the Radix Notoginseng powder is adjuvant drug, is messenger drug with flacourtia rukam stone, earlier with Ophicalcitum, flacourtia rukam stone is forged, quench in vinegar, is ground foam and water flies through fire respectively, again with the Pseudobulbus Bletillae (Rhizoma Bletillae) through drying, porphyrize and sieving, and then select materials and the Radix Notoginseng powder mix homogeneously with above-mentioned, form after sterilization, its part by weight of respectively selecting materials is an Ophicalcitum: the Pseudobulbus Bletillae (Rhizoma Bletillae): Radix Notoginseng powder: flacourtia rukam stone=40: 30: 20: 10 again.
The invention has the advantages that it has good local hemostasis effect, can make hemagglutination, form artificial thrombosis, impel the growth and the healing of skin ulcer face granulation tissue.The calcium ion concentration that can promote in the blood for oral administration raises, and makes blood vessel and lymph node densification, prevents that blood plasma from oozing out, and promotes blood coagulation.External can be stopped blooding rapidly, and the molten disconnected and absorption skin ulcer face exudate of energy part has the effect of convergence protection wound, and it is fast to stop blooding, and it is fast to form a scab, and does not infect, and is not afraid of the water logging sweat stain, and has no side effect.
The present invention is further described with embodiment below:
The present invention selects for use Chinese crude drug Ophicalcitum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Notoginseng powder and flacourtia rukam stone as raw material, earlier Ophicalcitum, flacourtia rukam stone are forged, quench in vinegar, ground foam and water flies through fire respectively, again with the Pseudobulbus Bletillae (Rhizoma Bletillae) after drying, grind foam and sieving with 800 purposes sieves, and then select materials and the Radix Notoginseng powder mix homogeneously above-mentioned, again through forming in 1 hour with disinfection by ultraviolet light.Its part by weight of respectively selecting materials is an Ophicalcitum: the Pseudobulbus Bletillae (Rhizoma Bletillae): Radix Notoginseng powder: flacourtia rukam stone=40: 30: 20: 10.

Claims (1)

  1. A kind of hemostatic Chinese medicine drug hemostasis that is used for is loose, it is characterized in that it is to select for use Chinese medicine medical material Ophicalcitum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Notoginseng powder and flacourtia rukam stone to do raw material, earlier Ophicalcitum, flacourtia rukam stone are forged, quench in vinegar, ground foam and water flies through fire respectively, again with the Pseudobulbus Bletillae (Rhizoma Bletillae) through drying, grind foam and sieving, and then with above-mentioned select materials with the Radix Notoginseng powder mix homogeneously again after sterilizing and obtain, its part by weight of respectively selecting materials is an Ophicalcitum: the Pseudobulbus Bletillae (Rhizoma Bletillae): Radix Notoginseng powder: flacourtia rukam stone=40: 30: 20: 10.
CN94107005A 1994-06-06 1994-06-06 Styptic powder Expired - Fee Related CN1051236C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94107005A CN1051236C (en) 1994-06-06 1994-06-06 Styptic powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94107005A CN1051236C (en) 1994-06-06 1994-06-06 Styptic powder

Publications (2)

Publication Number Publication Date
CN1097622A true CN1097622A (en) 1995-01-25
CN1051236C CN1051236C (en) 2000-04-12

Family

ID=5032752

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94107005A Expired - Fee Related CN1051236C (en) 1994-06-06 1994-06-06 Styptic powder

Country Status (1)

Country Link
CN (1) CN1051236C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100453070C (en) * 2003-12-13 2009-01-21 昆明紫健生物技术有限公司 Aseptic dry powder spray agent and production method in use for stopping the blood and diminishing inflammation in wound
CN102940854A (en) * 2012-11-27 2013-02-27 陈兴旺 Traditional Chinese medicine composition for facilitating wound healing after surgical operations, preparation process and application
CN102961603A (en) * 2012-12-07 2013-03-13 大连创达技术交易市场有限公司 Hemostatic
CN105106642A (en) * 2015-09-09 2015-12-02 南方医科大学 Traditional Chinese medicine composition for treating traumatic injuries
CN106458622A (en) * 2014-05-20 2017-02-22 默克专利股份有限公司 Alpha-Al[2]O[3] flakes
CN108478721A (en) * 2018-05-29 2018-09-04 广州聚澜健康产业研究院有限公司 A kind of astringing to arrest bleeding frost and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1192787C (en) * 2002-03-08 2005-03-16 天津天士力制药股份有限公司 Chinese medicine for treating ulcerative colitis and its preparing process

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100453070C (en) * 2003-12-13 2009-01-21 昆明紫健生物技术有限公司 Aseptic dry powder spray agent and production method in use for stopping the blood and diminishing inflammation in wound
CN102940854A (en) * 2012-11-27 2013-02-27 陈兴旺 Traditional Chinese medicine composition for facilitating wound healing after surgical operations, preparation process and application
CN102961603A (en) * 2012-12-07 2013-03-13 大连创达技术交易市场有限公司 Hemostatic
CN106458622A (en) * 2014-05-20 2017-02-22 默克专利股份有限公司 Alpha-Al[2]O[3] flakes
CN105106642A (en) * 2015-09-09 2015-12-02 南方医科大学 Traditional Chinese medicine composition for treating traumatic injuries
CN108478721A (en) * 2018-05-29 2018-09-04 广州聚澜健康产业研究院有限公司 A kind of astringing to arrest bleeding frost and preparation method thereof

Also Published As

Publication number Publication date
CN1051236C (en) 2000-04-12

Similar Documents

Publication Publication Date Title
CN101919927B (en) Spray for promoting scald healing
CN1051236C (en) Styptic powder
CN108686103B (en) Hemostatic traditional Chinese medicine composition and multifunctional emergency hemostatic composite material
CN104225258A (en) Traditional Chinese medicine composition for promoting wound healing
CN103055102A (en) Traditional Chinese medicine used for stopping bleeding, relieving pain and promoting tissue regeneration of wound
CN104984249A (en) Composition for treating scalds and preparation method thereof
CN104940627A (en) Traditional Chinese medicine composition for promoting wound healing, and preparation method of traditional Chinese medicine composition
CN104815172A (en) Scald ointment as well as preparation method and application method of scald ointment
CN1055013C (en) Method for prepn. of Chinese medicinal external application ointment for diminishing inflammation, stopping pain and setting fracture
CN103223077B (en) Traditional Chinese medicine composition for treating burn and scald
CN102028875B (en) Medicament for treating open wound and preparation method thereof
CN101879254B (en) Chinese medicinal ointment for treating neonate omphalitis
CN103816247A (en) External Chinese medicinal composition capable of preventing scarring healing of external injury and preparation method for external Chinese medicinal composition
CN106620369A (en) Hemostatic traditional Chinese medicine powder for external use
CN1045034A (en) The manufacture method of Chinese herbal medicine mixture for burn
CN101152290A (en) Externally used powder preparation stypticum
CN112121119B (en) Ointment for treating hydrofluoric acid burn
CN117860845A (en) Prescription of trauma specific medicine and preparation method thereof
CN104306772A (en) Traditional Chinese medicine composition for treating radiodermatitis and preparation method of traditional Chinese medicine composition
CN1103596C (en) Burn-treating medicine powder and its preparation
CN105079142A (en) External hemostatic drug
CN105617273A (en) Pharmaceutic preparation for promoting wound healing and application thereof
CN1096208A (en) Removing sludging bone junction powder
CN105079696A (en) External hemostatic drug
CN1179730C (en) Wound-treating external-use medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee